» Articles » PMID: 30683134

MicroRNA-29a Activates a Multi-component Growth and Invasion Program in Glioblastoma

Overview
Publisher Biomed Central
Specialty Oncology
Date 2019 Jan 27
PMID 30683134
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glioblastoma is a malignant brain tumor characterized by rapid growth, diffuse invasion and therapeutic resistance. We recently used microRNA expression profiles to subclassify glioblastoma into five genetically and clinically distinct subclasses, and showed that microRNAs both define and contribute to the phenotypes of these subclasses. Here we show that miR-29a activates a multi-faceted growth and invasion program that promotes glioblastoma aggressiveness.

Methods: microRNA expression profiles from 197 glioblastomas were analyzed to identify the candidate miRNAs that are correlated to glioblastoma aggressiveness. The candidate miRNA, miR-29a, was further studied in vitro and in vivo.

Results: Members of the miR-29 subfamily display increased expression in the two glioblastoma subclasses with the worst prognoses (astrocytic and neural). We observed that miR-29a is among the microRNAs that are most positively-correlated with PTEN copy number in glioblastoma, and that miR-29a promotes glioblastoma growth and invasion in part by targeting PTEN. In PTEN-deficient glioblastoma cells, however, miR-29a nevertheless activates AKT by downregulating the metastasis suppressor, EphB3. In addition, miR-29a robustly promotes invasion in PTEN-deficient glioblastoma cells by repressing translation of the Sox4 transcription factor, and this upregulates the invasion-promoting protein, HIC5. Indeed, we identified Sox4 as the most anti-correlated predicted target of miR-29a in glioblastoma. Importantly, inhibition of endogenous miR-29a decreases glioblastoma growth and invasion in vitro and in vivo, and increased miR-29a expression in glioblastoma specimens correlates with decreased patient survival.

Conclusions: Taken together, these data identify miR-29a as a master regulator of glioblastoma growth and invasion.

Citing Articles

Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma.

Ali E, Ahmed M, Shawki M, El Arab L, Khalifa M, Swellam M Sci Rep. 2025; 15(1):1933.

PMID: 39809835 PMC: 11733229. DOI: 10.1038/s41598-024-83800-x.


The Role of Non-Coding RNAs in Glioma.

Goenka A, Tiek D, Song X, Iglesia R, Lu M, Hu B Biomedicines. 2022; 10(8).

PMID: 36009578 PMC: 9405925. DOI: 10.3390/biomedicines10082031.


YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-κB signalling pathways via inhibiting EPHB3 and TNFAIP3.

Chen Y, Wang Y, Qiu K, Cao Y, Zhang F, Zhao H Clin Transl Immunology. 2022; 11(5):e1393.

PMID: 35582627 PMC: 9082891. DOI: 10.1002/cti2.1393.


Molecular Insights and Prognosis Associated With RBM8A in Glioblastoma.

Wei L, Zou C, Chen L, Lin Y, Liang L, Hu B Front Mol Biosci. 2022; 9:876603.

PMID: 35573726 PMC: 9098818. DOI: 10.3389/fmolb.2022.876603.


Interplay of SOX transcription factors and microRNAs in the brain under physiological and pathological conditions.

Stevanovic M, Stanisavljevic Ninkovic D, Mojsin M, Drakulic D, Schwirtlich M Neural Regen Res. 2022; 17(11):2325-2334.

PMID: 35535866 PMC: 9120710. DOI: 10.4103/1673-5374.338990.


References
1.
Thomas G, Frame S, Goedert M, Nathke I, Polakis P, Cohen P . A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett. 1999; 458(2):247-51. DOI: 10.1016/s0014-5793(99)01161-8. View

2.
Nishiya N, Tachibana K, Shibanuma M, Mashimo J, Nose K . Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase. Mol Cell Biol. 2001; 21(16):5332-45. PMC: 87257. DOI: 10.1128/MCB.21.16.5332-5345.2001. View

3.
Chan J, Krichevsky A, Kosik K . MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005; 65(14):6029-33. DOI: 10.1158/0008-5472.CAN-05-0137. View

4.
Phillips H, Kharbanda S, Chen R, Forrest W, Soriano R, Wu T . Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006; 9(3):157-73. DOI: 10.1016/j.ccr.2006.02.019. View

5.
Guignandon A, Boutahar N, Rattner A, Vico L, Lafage-Proust M . Cyclic strain promotes shuttling of PYK2/Hic-5 complex from focal contacts in osteoblast-like cells. Biochem Biophys Res Commun. 2006; 343(2):407-14. DOI: 10.1016/j.bbrc.2006.02.162. View